The combination of lenalidomide, bortezomib, and dexamethasone (RVD) has become a standard induction therapy for patients with multiple myeloma, whether or not they are candidates for autologous ...
Phase 2 study of ASTX727 (cedazuridine/decitabine) plus venetoclax (ven) in patients with relapsed/refractory acute myeloid leukemia (AML) or previously untreated ...
CHICAGO -- Patients with undetectable disease after induction therapy for newly diagnosed multiple myeloma (NDMM) did not have significantly better outcomes with a stem-cell transplant versus drug ...
Chemotherapy is a drug therapy that’s used to treat many different types of cancer. Chemicals in chemotherapy drugs target cells that rapidly divide, such as cancer cells. They may also target healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback